PD-MitoQUANT is an Innovative Medicines Initiative (IMI) project that brings together academic experts, SMEs, pharmaceutical companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA) and patient advocacy organisation Parkinson’s UK to:

  • improve our understanding of mitochondrial dysfunction in Parkinson’s,
  • identify and validate molecular drivers and mechanisms in Parkinson’s, and
  • discover innovative therapeutic targets that can be further progressed by the EFPIA partners in the future.

08/03/2019, PD MitoQUANT Kick Off Meeting at RCSI, 123 St. Stephen’s Green, Dublin 2. (Picture: Lafayette Photography)

A project press release was issued on 12 March 2019 following the launch and kick-off meeting. Below is a list of international and national media coverage of the launch of PD-MitoQUANT:

  • Bioengineer.org: Ireland to lead €7 million Parkinson’s research project. Read the story here.
  • SCIENMAG: Ireland to lead €7 million Parkinson’s research project. Read the story here.
  • Hospital Pharmacy Europe: Ireland to lead on €7 million Parkinson’s research project. Read the story here.
  • Bio Spectrum Asia: Ireland to lead €7 M Parkinson’s research project. Read the story here.
  • SiliconRepublic.com: Ireland’s RCSI to lead €7m Parkinson’s research project. Read the story here.
  • Irish Mirror: €7m boost for research into Parkinson’s. Read the story here.
  • Noticias de Salud: Ireland to lead €7 million Parkinson’s research project. Read the story here.
  • ManufacturingChemist.com: Ireland to lead €7 million Parkinson’s research project. Read the story here.
  • Irishhealth.com: Irish team lead major Parkinson’s project. Read the story here.
  • BioSpectrum: Ireland to lead €7 million Parkinson’s research project. Read the story here.
  • TheInnersane.com: Irish Unit lead preeminent Parkinson’s task. Read the story here.
  • Pharma Business International: New research study exploring better Parkinson’s treatments. Read the story here.
  • BioPortfolio: €7m project aims to deepen understanding of Parkinson’s. Read the story here.
  • European Pharmaceutical Manufacturer: €7m project aims to deepen understanding of Parkinson’s. Read the story here.
  • CPhI.cn: Irish scientists secure EU funding for Parkinson’s research project. Read the story here.
  • Pharma Technology Focus; pharmaceuticaltechnology.com: Parkinson’s disease research project secures EU funding. Read the story here.
  • Site Selection Online Magazine: Briefly Bio. Read the story here.
  • Hospital Healthcare Europe: Ireland to lead on €7 million Parkinson’s research project. Read the story here.

 

PD-MitoQUANT has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.